Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. More Details
Flawless balance sheet with outstanding track record.
Share Price & News
How has Drägerwerk KGaA's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: Insufficient data to determine DRW8D's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine DRW8D's volatility change over the past year.
7 Day Return
GB Medical Equipment
1 Year Return
GB Medical Equipment
Return vs Industry: DRW8D underperformed the UK Medical Equipment industry which returned 2.7% over the past year.
Return vs Market: DRW8D underperformed the UK Market which returned 26.3% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Drägerwerk KGaA's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Drägerwerk KGaA undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: DRW8D (€61.6) is trading above our estimate of fair value (€60.64)
Significantly Below Fair Value: DRW8D is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: DRW8D is good value based on its PE Ratio (7.3x) compared to the GB Medical Equipment industry average (49.5x).
PE vs Market: DRW8D is good value based on its PE Ratio (7.3x) compared to the UK market (26.4x).
Price to Earnings Growth Ratio
PEG Ratio: DRW8D's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: DRW8D is good value based on its PB Ratio (1.4x) compared to the GB Medical Equipment industry average (3.8x).
How is Drägerwerk KGaA forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DRW8D's earnings are forecast to decline over the next 3 years (-18.8% per year).
Earnings vs Market: DRW8D's earnings are forecast to decline over the next 3 years (-18.8% per year).
High Growth Earnings: DRW8D's earnings are forecast to decline over the next 3 years.
Revenue vs Market: DRW8D's revenue (0.6% per year) is forecast to grow slower than the UK market (5.3% per year).
High Growth Revenue: DRW8D's revenue (0.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DRW8D's Return on Equity is forecast to be low in 3 years time (8.6%).
How has Drägerwerk KGaA performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: DRW8D has high quality earnings.
Growing Profit Margin: DRW8D's current net profit margins (7.8%) are higher than last year (1%).
Past Earnings Growth Analysis
Earnings Trend: DRW8D's earnings have grown significantly by 34.7% per year over the past 5 years.
Accelerating Growth: DRW8D's earnings growth over the past year (868.7%) exceeds its 5-year average (34.7% per year).
Earnings vs Industry: DRW8D earnings growth over the past year (868.7%) exceeded the Medical Equipment industry 13.8%.
Return on Equity
High ROE: DRW8D's Return on Equity (29.3%) is considered high.
How is Drägerwerk KGaA's financial position?
Financial Position Analysis
Short Term Liabilities: DRW8D's short term assets (€2.0B) exceed its short term liabilities (€948.0M).
Long Term Liabilities: DRW8D's short term assets (€2.0B) exceed its long term liabilities (€1.1B).
Debt to Equity History and Analysis
Debt Level: DRW8D's debt to equity ratio (14.7%) is considered satisfactory.
Reducing Debt: DRW8D's debt to equity ratio has reduced from 36.5% to 14.7% over the past 5 years.
Debt Coverage: DRW8D's debt is well covered by operating cash flow (286.8%).
Interest Coverage: DRW8D's interest payments on its debt are well covered by EBIT (17.4x coverage).
What is Drägerwerk KGaA current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: DRW8D's dividend (0.25%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.35%).
High Dividend: DRW8D's dividend (0.25%) is low compared to the top 25% of dividend payers in the UK market (4.03%).
Stability and Growth of Payments
Stable Dividend: DRW8D is not paying a notable dividend for the UK market, therefore no need to check if payments are stable.
Growing Dividend: DRW8D is not paying a notable dividend for the UK market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: DRW8D is not paying a notable dividend for the UK market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of DRW8D's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Stefan Dräger (57 yo)
Mr. Stefan A. Dräger, Dipl.-Ing. B.A., has been the Chief Executive Officer and Chairman of the Executive Board at Drägerwerk Verwaltungs AG, a General Partner of Drägerwerk AG & Co. KGaA (formerly known a...
CEO Compensation Analysis
Compensation vs Market: Stefan's total compensation ($USD3.86M) is above average for companies of similar size in the UK market ($USD1.36M).
Compensation vs Earnings: Stefan's compensation has increased by more than 20% in the past year.
Experienced Management: DRW8D's management team is seasoned and experienced (5.9 years average tenure).
Experienced Board: DRW8D's board of directors are considered experienced (9.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.3%.
Drägerwerk AG & Co. KGaA's company bio, employee growth, exchange listings and data sources
- Name: Drägerwerk AG & Co. KGaA
- Ticker: DRW8D
- Exchange: BATS-CHIXE
- Founded: 1889
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: €1.406b
- Shares outstanding: 18.76m
- Website: https://www.draeger.com
Number of Employees
- Drägerwerk AG & Co. KGaA
- Moislinger Allee 53-55
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, a...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/10 00:45|
|End of Day Share Price||2021/03/02 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.